Business Context and Reporting Period
Seastar Medical Holding Corp (ICU) filed this Form 8-K on March 6, 2024, regarding a listing status update with The Nasdaq Stock Market. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing standards.
Material Changes
The primary event reported is the receipt of a letter from the Nasdaq Listing Qualifications Department granting the company a temporary exception to regain compliance with Nasdaq Listing Rule 5550(a)(2), the Minimum Bid Price Rule. Previously, the company's common stock traded below $1.00 per share for 30 consecutive business days ending June 26, 2023.
Guidance, Outlook, and Risks
- Compliance Deadline: The company has until June 24, 2024, to demonstrate a closing bid price of $1.00 or more per share for a minimum of ten consecutive trading sessions.
- Contingency Plan: The company submitted a plan to the Nasdaq Hearings Panel that includes conducting a reverse stock split if necessary, no later than June 7, 2024.
- Risks: Management stated there can be no assurance that the company will regain compliance with the Minimum Bid Price Rule or remain in compliance with other applicable Nasdaq listing standards. Failure to comply could result in delisting.
Investor Verification Checklist
- Monitor the daily closing bid price of ICU common stock to track progress toward the $1.00 threshold.
- Verify if the company announces a reverse stock split prior to the June 7, 2024 deadline.
- Confirm the company's status regarding the ten consecutive trading sessions requirement by June 24, 2024.
- Review subsequent filings for any updates on the Nasdaq Hearings Panel decision or further deficiency notices.